2025
SJR Q1
JCR Q1 · 47,8
OA
10 matched articles
SCIE
Journal detail
Journal of Hematology and Oncology
- Publisher
- BioMed Central Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
17568722
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 11,824
- Quartile Q1
- H-Index 194
- Cites/doc 28,48
- Docs (3y) 406
- Cites (3y) 12.988
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 47,8
- 5Y JIF 42,7
- JCI 5,93
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cancer Research Q1
- Hematology Q1
- Molecular Biology Q1
- Oncology Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Oncology | Hematology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 11,824 | 47,8 | 42,7 | 5,93 | Q1 | 194 |
| 2024 | Q1 | Q1 | 10,192 | 40,4 | 34,4 | 5,05 | Q1 | 171 |
| 2023 | Q1 | Q1 | 7,522 | 29,9 | 27,1 | 4,2 | Q1 | 171 |
| 2022 | Q1 | Q1 | 6,046 | 28,5 | 23,1 | 3,57 | Q1 | 171 |
| 2021 | Q1 | Q1 | 4,241 | 23,2 | 17,5 | 2,86 | Q1 | 171 |
| 2020 | Q1 | Q1 | 4,305 | 17,4 | 12,6 | 2,41 | Q1 | 171 |
| 2019 | Q1 | Q1 | 3,231 | 11,1 | 8,5 | 2,05 | Q1 | 171 |
| 2018 | — | Q1 | — | 8,7 | 7,4 | 1,78 | Q1 | — |
| 2017 | Q1 | Q1 | 2,292 | 7,3 | 6,5 | 1,43 | Q1 | 171 |
| 2016 | Q1 | Q1 | 2,452 | 6,3 | 5,9 | — | — | 171 |
| 2015 | Q1 | Q1 | 2,331 | 6,3 | 5,4 | — | — | 171 |
| 2014 | Q1 | Q1 | 1,856 | 4,8 | 4,4 | — | — | 171 |
| 2013 | Q1 | Q1 | 1,869 | 4,9 | 4,4 | — | — | 171 |
| 2012 | Q1 | Q1 | 1,604 | 4,5 | 4,1 | — | — | 171 |
| 2011 | Q1 | Q2 | 1,712 | 4 | 3,7 | — | — | 171 |
| 2010 | Q2 | Q2 | 0,95 | 2,9 | 2,9 | — | — | 171 |
| 2009 | — | Q4 | — | 1,4 | 1,4 | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | HEMATOLOGY | SCIE | Q1 | Q1 | 1/103 |
| 2025 | ONCOLOGY | SCIE | Q1 | Q1 | 6/333 |
| 2024 | HEMATOLOGY | SCIE | Q1 | Q1 | 1/99 |
| 2024 | ONCOLOGY | SCIE | Q1 | Q1 | 7/328 |
| 2023 | HEMATOLOGY | SCIE | Q1 | Q1 | 1/97 |
| 2023 | ONCOLOGY | SCIE | Q1 | Q1 | 9/322 |
| 2022 | HEMATOLOGY | SCIE | Q1 | Q1 | 1/79 |
| 2022 | ONCOLOGY | SCIE | Q1 | Q1 | 10/241 |
| 2021 | HEMATOLOGY | SCIE | Q1 | Q1 | 4/78 |
| 2021 | ONCOLOGY | SCIE | Q1 | Q1 | 12/245 |
| 2020 | HEMATOLOGY | SCIE | Q1 | Q1 | 3/76 |
| 2020 | ONCOLOGY | SCIE | Q1 | Q1 | 11/242 |
| 2019 | HEMATOLOGY | SCIE | Q1 | Q1 | 3/76 |
| 2019 | ONCOLOGY | SCIE | Q1 | Q1 | 15/244 |
| 2018 | HEMATOLOGY | SCIE | Q1 | Q1 | 5/73 |
| 2018 | ONCOLOGY | SCIE | Q1 | Q1 | 18/230 |
| 2017 | HEMATOLOGY | SCIE | Q1 | Q1 | 6/71 |
| 2017 | ONCOLOGY | SCIE | Q1 | Q1 | 24/223 |
| 2016 | HEMATOLOGY | SCIE | Q1 | — | 7/70 |
| 2016 | ONCOLOGY | SCIE | Q1 | — | 26/217 |
| 2015 | HEMATOLOGY | SCIE | Q1 | — | 6/70 |
| 2015 | ONCOLOGY | SCIE | Q1 | — | 21/213 |
| 2014 | HEMATOLOGY | SCIE | Q1 | — | 12/68 |
| 2014 | ONCOLOGY | SCIE | Q1 | — | 35/211 |
| 2013 | HEMATOLOGY | SCIE | Q1 | — | 12/68 |
| 2013 | ONCOLOGY | SCIE | Q1 | — | 36/203 |
| 2012 | HEMATOLOGY | SCIE | Q1 | — | 15/67 |
| 2012 | ONCOLOGY | SCIE | Q1 | — | 44/197 |
| 2011 | HEMATOLOGY | SCIE | Q2 | — | 19/68 |
| 2011 | ONCOLOGY | SCIE | Q2 | — | 50/196 |
| 2010 | HEMATOLOGY | SCIE | Q2 | — | 28/66 |
| 2010 | ONCOLOGY | SCIE | Q2 | — | 71/185 |
| 2009 | HEMATOLOGY | SCIE | Q4 | — | 46/61 |
| 2009 | ONCOLOGY | SCIE | Q4 | — | 128/166 |